english.prescrire.org > Prescrire International > N°262 - September 2024

n°262

September 2024

Issue Contents
Editorial

Free  Phasing out patient leaflets in paper form: eco-responsible or irresponsible?

p.199

Marketing Authorisations


Selinexor (Nexpovio°) in relapsed or refractory multiple myeloma

p.201-203

Lonafarnib (Zokinvy°) in progeria

p.204-205

Semaglutide injections (Wegovy°) in obesity in adolescents

p.206

Avapritinib (Ayvakyt°) in advanced systemic mastocytosis

p.207

Bimekizumab (Bimzelx°) in axial spondyloarthritis or psoriatic arthritis

p.208

Olipudase alfa (Xenpozyme°) in acid sphingomyelinase deficiency type B or A/B

p.209-210

Topiramate and risks associated with pregnancy: European measures

p.210

Omega-3 polyunsaturated fatty acids: dose-dependent risk of atrial fibrillation downplayed in the SmPCs

p.211

Bupropion + naltrexone (Mysimba°) for weight loss: set to be withdrawn from the market in the European Union?

p.212

Pseudoephedrine-containing medicines in the common cold: the EMA misses an opportunity to protect patients

p.213

Setmelanotide (Imcivree°) in Bardet-Biedl syndrome

p.214

Adverse Effects


In-utero exposure to corticosteroids: increased risk of serious infections during the first year of life

p.215

Opioid replacement therapy during pregnancy: buprenorphine appears less dangerous than methadone for the unborn child

p.216

Sertaconazole or econazole during pregnancy: no particular safety signal for the unborn child

p.217

CAR T-cell therapies: secondary T-cell lymphomas

p.217

Caftors: depression, anxiety, suicide

p.218

Common stem: -relin, -relix

p.218

Outlook


Free  Prescrire's review of drug packaging in 2023: reconciling ease of use with safety is an ongoing challenge

p.219-222

Prescrire's contribution to the EMA's consultation on the "Concept Paper for the Development of a Guideline on Non-Inferiority and Equivalence Comparisons in Clinical Trials"

p.223

Masthead


Free  Masthead

p.198

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe